Patent-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmics
Lead Participant:
UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST | £9,979 | £ 9,979 |
Participant |
||
| CELL AND GENE THERAPY CATAPULT | £13,887 | £ 13,887 |
| UNIVERSITY OF BIRMINGHAM | £136,974 | £ 136,974 |
| THE CHRISTIE NHS FOUNDATION TRUST | £12,000 | £ 12,000 |
People |
ORCID iD |
| Finn Willingham (Project Manager) |